gvtcx

HIV Medicines

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£89,900,000
Statuscomplete
Category (CPV) 33600000
RegionScotland
Deadline4 Feb 2026
Procedureopen
OCIDocds-h6vhtk-05ff84

Awards (14)

This procurement was awarded to 14 suppliers. Values shown are per-award; the notice total is £89,900,000.

SupplierValueDateStatus
Amarox Limited shared · · active
CST Pharma Ltd shared · · active
Dr Reddy's Laboratories (UK) Ltd shared · · active
Gilead Sciences Ltd shared · · active
Glenmark Pharmaceuticals Europe Ltd shared · · active
Janssen-Cilag Ltd shared · · active
Lupin Healthcare UK Ltd shared · · active
Merck Sharp & Dohme UK Ltd shared · · active
Milpharm Limited shared · · active
MSN Labs shared · · active
Orifarm UK Ltd shared · · active
Sun Pharma UK Ltd shared · · active
Viatris UK Healthcare Ltd shared · · active
ViiV Healthcare UK Ltd shared · · active

description

Supply of HIV Medicines to NHS Scotland

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
5 Jan 2026 Contract notice (F02) Earlier regulations 000393-2026
7 May 2026 Contract award notice (F03) Earlier regulations 042069-2026

more from The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.